World Hepatitis Alliance Geneva, 2024. 222p.
Detailed abstracts covering innovations, advocacy, stigma, mother-child transmission, children, monitoring & surveillance, partnerships, financing , lived experience, universal health coverage etc.
World Health Organization, Geneva, 2024. 223p.
This report presents the latest estimates on the disease burden and the coverage of essential viral hepatitis services from 187 countries across the world and updated progress made since 2019.
Filter, New York, 2024. 9p.
Looks at various models of care, accessibility of treatment and funding models from around the globe that can turn elimination into a reality.
Lancet Gastroeneterology and Hepatology, (via Elsevier), London, 2024. 20p.
National experts from each of the top 20 highest burdened countries provide an update: progress in elimination policy has been made in 14 of 20 countries with the highest burden since 2018. Register (free) to access.
World Health Organization, Geneva, 2024. 270p.
Provides updated evidence-informed recommendations on key priority topics, including simplified treatment; antiviral prophylaxis for pregnant women; improving HBV diagnostics; and approaches to promote delivery of high-quality HBV services.
Open Forum Infectious Diseases (Oxford University Press), Oxford, 2024. 9p.
This article highlights a potential avenue for healthcare improvement by implementing combination testing programs.
World Hepatitis Alliance, Geneva, 2024. 5p.
Briefing paper that outlines statistics and key facts about the connection between viral hepatitis and liver cancer.
Drug Science, London, 2023. 185p.
Includes a summary of existing evidence suggesting that OPCs are successful in reducing drug-related harms for individuals and communities, through the prevention of overdoses and improved access to other health services.
Coalition for Global Hepatitis Elimination, Decatur GA, 2024. 26p.
Provides a path forward to identify barriers, learn while doing, and establish simplified approaches to hepatitis B testing, care, and treatment in order to improve global health equity and save lives.
Infectious Disease Advisor, New York, 2024. 2p. article review.
Overview of a multinational longitudinal study to assess changes in the incidence of HCV reinfection among at-risk patients with HIV infection during periods of limited and broad access to DAA therapy. Contains link to original article.
Liver Foundation, Melbourne, 2022. 3p.
Lists the most common symptoms that may indicate poor liver health or liver disease. Each symptom description links to further, more detailed, information.
American College of Lifestyle Medicine, Chesterfield MO, undated. 18p.
7 days of fully illustrated meal plans (including snacks) featuring plant-based recipes, with nutritional information and weekly shopping list. With a section of ingredient substitutions for a range of allergies.
Int Journal of Drug Policy, London, 2024. 12p.
Women who inject drugs face gendered barriers to care that impact on engagement with HCV services.
JAMA Pediatrics, (American Medical Assoc), Chicago, 2024. 1p detailed abstract.
In this cost-effectiveness analysis, results demonstrated that treating 3-year-olds with perinatally acquired HCV was projected to increase life expectancy and decrease health care costs.
World Hepatitis Alliance, Geneva, 2024. 5p.
Briefing document jointly released by the World Hepatitis Alliance and INHSU sheds light on the unique challenges faced by women living with viral hepatitis.
World Hepatitis Alliance, Geneva, 2024. Video 1:27:39
WHA hosted a panel discussion to explore the unique perspectives of women living with hepatitis and to celebrate women that are driving the hepatitis response and supporting other women living with hepatitis.
INHSU Prisons, Geneva, 2024. 13p.
An interactive workshop sharing global best practice for the scale up of HCV testing, treatment and prevention services in prisons.
Hepatitis Foundation of New Zealand, Whakatāne, 2019. 2p. Brochure.
General lifestyle information about healthy living and dealing with hepatitis symptoms. Check library catalogue for Samoan version.
Internal Medicine Journal, Melbourne, 2024. 9p.
Current approaches are failing to deliver optimal care to Indigenous Australians in regional Nth Queensland. Targeted strategies are urgently needed.
National Drug & Alcohol Research Centre (NDARC), Sydney, 2024. Webinar 57 minutes.
Investigates the health challenges of those who have been incarcerated and how these problems can be identified as early as possible to inform targeted interventions aimed at improving the health of this group.
Lancet Gastroeneterology and Hepatology (via Elsevier), London, 2024. 2p.
Insufficient access to hepatitis services, stigma and discrimination, low awareness, inadequate political will, and insufficient financing continue to slow progress. Civil society organisations are uniquely positioned to address these barriers.
For enquiries or feedback, please contact the librarian at Librarian@hepatitissa.asn.au.
| Address: | 3 Hackney Road Hackney SA 5069 |
| Phone: | (08) 8362 8443 |
| Fax: | (08) 8362 8559 |
| Email: | Librarian@hepatitissa.asn.au |
| Post: | PO Box 782 Kent Town SA 5071 |
Monday – Friday
9am to 5pm
Hepatitis SA is a non-profit, community-based organisation that provides information, education and support services to South Australians affected by hepatitis B and hepatitis C.